On March 20, 2017, Clement Okoh walked into a Lagos hospital with what previous doctors he consulted believed was a muscle strain and routine pain. Hours later, he said he could no longer walk.
He later learnt the muscle strain diagnosis was incorrect. What had been dismissed as routine pain was later diagnosed as aggressive multiple myeloma—blood cancer that develops in plasma cells—eating away at his spine. By the time the error became clear, the damage was severe. The tumour had weakened his vertebrae —the bones that form the human spinal column—so much that a minor fall was enough to fracture his spine and leave him paralysed.
Within hours, Okoh said he was flown to the United States. The doctors at John Hopkins Hospital, in Baltimore, Maryland, USA, he said, gave him four to five years to live, with a range of immediate risks: stroke, pulmonary embolism, deep vein thrombosis, blood poisoning, and internal bleeding. Surgeons removed the tumour and fused his spine. Okoh recalled his neurosurgeon once telling him that he would never walk again. But he did.
That recovery did more than save his life; it shaped his direction afterwards. During his time in intensive care and rehabilitation, he resolved that if he survived, he would return to Nigeria and work on building systems that could reduce the chances of similar outcomes in the future.
Become a TC Insider for free to finish this story.
Sign in to read the full story and stay ahead of Africa's tech ecosystem.
